RISKIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Riskified Ltd. – RSKD June 25, 2022 NEW ORLEANS, June 24, 2022 — Kahn Swick & Foti,
RISKIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: KAHN SWICK & FOTI, LLC REMINDS INVESTORS WITH LOSSES IN EXCESS OF $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Riskified Ltd. – RSKD May 28, 2022 NEW ORLEANS, May 27, 2022 — Kahn Swick & Foti,
Jiangsu Hengrui Pharmaceuticals Co., Ltd. (Hengrui Pharma) launches Luzsana Biotechnologyâ„¢ (Luzsana) May 18, 2022 Luzsana to co-develop medicines with parent company Hengrui Pharma and
RISKIFIED SHAREHOLDER ALERT BY FORMER LOUISIANA ATTORNEY GENERAL: Kahn Swick & Foti, LLC Reminds Investors with Losses in Excess of $100,000 of Lead Plaintiff Deadline in Class Action Lawsuit Against Riskified Ltd. – RSKD May 14, 2022 NEW ORLEANS, May 13, 2022 — Kahn Swick & Foti,